Toward a Generic Approach for Stress Testing of Drug Substances and Drug Products

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-02-02-2005, Volume 29, Issue 2

The Impurity Profiling Group reviews stress testing according to regulatory guidance documents. The authors emphasize what should be considered for late clinical phases and for registration application dossiers.

Related Content:

AnalyticsFormulationManufacturingQuality SystemsGeneric DrugsDevelopmentPharmaceutical Technology-02-02-2005
Facing the Future of Aseptic Manufacturing
A Four-Phased Approach for Evaluating a Quality Risk Management Activity
Overcoming the Poor Solubility of Cannabinoids